Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. is a leading biopharmaceutical company founded in 1988 by Leonard S. Schleifer and George Yancopoulos. Based in Tarrytown, NY, Regeneron has grown to become one of the largest employers in Westchester County with over 5,500 employees worldwide. The company’s mission is to use the power of science to bring new medicines to patients that help them live healthier and longer lives by producing breakthrough treatments for serious medical conditions such as high cholesterol, eye diseases, allergic and inflammatory conditions, cancer and infectious diseases. Regeneron focuses on developing innovative medicines through its research platform emphasizing antibody technologies that efficiently deliver drugs directly into cells and tissues where they can have maximum effect with minimum side effects for patients. This emphasis on high-impact innovation has resulted in multiple successful products being approved by the FDA including EYLEA® (aflibercept), Praluent® (alirocumab), Dupixent® (dupilumab) and Kevzara™ (sarilumab).
Headquarters
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY 10591